Latest Breaking News On - Research advances in bone - Page 1 : comparemela.com

BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (NASDAQ:INZY) ("Inozyme" or the "Company"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of

United statesInozyme pharmaSagar nigwekarStefan rileyMatt peraResearch advances in boneDrug administrationInozyme pharma incEuropean calcified tissue society congressCorporate communicationsAmerican society of nephrologyKidney research centerExchange commissionMmsc coAmerican societyKidney week